secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2023-11-16T23:59:59+00:00
Accession:  0001213900-23-087723
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne receives Notice of Allowance for drug-delivery neural probe patent
---------------------------------------------------------------------------

- USPTO issued Notice of Allowance for Patent App. 16/812,702 covering electrodes that deliver treatment agent to brain target.
- This is the third Notice of Allowance received by NeuroOne in recent months.
- Company expects patent issuance in the coming months.
- CEO says allowance strengthens IP portfolio and supports partnering for combination drug-delivery and sEEG recording.
- NeuroOne's portfolio now includes 3 allowed apps, 1 issued patent, 8 pending U.S. apps, and several foreign apps.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390023087723/0001213900-23-087723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390023087723/ea188543-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-087723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer